CD9 and COVID-19: We found that molecules involved in platelet degranulation (CD9, platelet factor 4 (PF4)), aggregation, and activation [CD9, CLEC1B (also known as CLEC2)] were upregulated dramatically in COVID-19 EVs, while none of these proteins were detectable in EVs from healthy donors (Fig. 2a).